DWP
CVS icon

Daymark Wealth Partners’s CVS Health CVS Stock Holding History

Daymark Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Buy
31,083
+879
+3% +$78.5K 0.08% 186
2026
Q1 		$2.17M Buy
30,204
+1,693
+6% +$130K 0.07% 199
2025
Q4 		$2.26M Sell
28,511
-319
-1% -$25.1K 0.07% 180
2025
Q3 		$2.17M Buy
28,830
+306
+1% +$21K 0.07% 184
2025
Q2 		$1.97M Sell
28,524
-4,443
-13% -$291K 0.07% 181
2025
Q1 		$2.23M Buy
32,967
+6,430
+24% +$385K 0.1% 160
2024
Q4 		$1.19M Sell
26,537
-64,160
-71% -$3.6M 0.05% 212
2024
Q3 		$5.7M Buy
90,697
+24,792
+38% +$1.45M 0.24% 89
2024
Q2 		$3.89M Sell
65,905
-148,121
-69% -$9.27M 0.18% 105
2024
Q1 		$17.1M Sell
214,026
-480
-0.2% -$36.7K 0.92% 23
2023
Q4 		$16.9M Sell
214,506
-23,266
-10% -$1.66M 1.04% 19
2023
Q3 		$16.6M Buy
237,772
+9,123
+4% +$646K 1.14% 18
2023
Q2 		$15.8M Buy
228,649
+41,632
+22% +$2.96M 1.17% 15
2023
Q1 		$13.9M Buy
187,017
+18,971
+11% +$1.59M 1.84% 11
2022
Q4 		$15.7M Buy
+168,046
New +$16.2M 2.77% 7

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Daymark Wealth Partners's CVS Position: Q2 2026 in Review

Daymark Wealth Partners increased its CVS Health (CVS) stake by 2.9% in Q2 2026, buying an estimated $78.5K and bringing the position to 31,083 shares worth $3.22M. The position accounts for 0.08% of the portfolio, ranked #186.

Daymark Wealth Partners first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $17.1M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Daymark Wealth Partners held 31,083 shares of CVS Health worth $3.22M as of Q2 2026.
  • Daymark Wealth Partners bought 879 CVS Health shares in Q2 2026, an estimated $78.5K.
  • CVS Health made up 0.08% of Daymark Wealth Partners's portfolio in Q2 2026, its #186 holding.
  • Daymark Wealth Partners first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • Daymark Wealth Partners's CVS Health position peaked at $17.1M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.